[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Editor's Correspondence
Nov 12, 2012

Drug-Eluting Stents Should Not Be Used in ST-Elevated Myocardial Infarction With Cardiogenic Shock

Author Affiliations

Author Affiliations: Service de Réanimation Polyvalente, Centre Hospitalier Universitaire de La Réunion, Saint Denis, France.

Arch Intern Med. 2012;172(20):1613-1614. doi:10.1001/archinternmed.2012.4418

De Luca and colleagues1 concluded from their meta-analysis that drug-eluting stents (DES) in the ST-elevated myocardial infarction (STEMI) setting are more efficient than bare-metal stents (BMS) in reducing target-vessel revascularization (TVR). One must remember that during STEMI, one of the most serious complications is cardiogenic shock, which is not well pinpointed in their study.